Ah, sorry. Yes multiples. My guestimate was based on long term pricing as Allkem laid out heading in/out of 2023 (below) which would be more relative to the NPV (usually based off of 15y forecast) That's assuming we get a good run with limited hickups in processing similar to GXY back in the day. So at 2.5k spod we are looking at 4.3b for life of mine (10y) excluding expenses. Seems a lot less daunting and hopefully we really are looking at getting near spot pricing as they insist.
- Forums
- ASX - By Stock
- Banter and general comments
Ah, sorry. Yes multiples. My guestimate was based on long term...
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $225.0M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $312.1K | 2.989M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
217 | 12598735 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 795015 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
217 | 12598735 | 0.100 |
8 | 260911 | 0.099 |
13 | 347922 | 0.098 |
5 | 357036 | 0.097 |
4 | 223581 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 795015 | 23 |
0.110 | 4172663 | 41 |
0.115 | 3423675 | 38 |
0.120 | 6659747 | 60 |
0.125 | 4255721 | 55 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online